Randomized Phase I Trial of the alpha-Synuclein Antibody Lu AF82422. Buur L, Wiedemann J, Larsen F, Ben Alaya-Fourati F, et al. Mov Disord 2024;39:936-944.

Read + Share

Amedeo Smart

Independent Medical Education

Buur L, Wiedemann J, Larsen F, Ben Alaya-Fourati F, et al. Randomized Phase I Trial of the alpha-Synuclein Antibody Lu AF82422. Mov Disord 2024;39:936-944.
PMID: 38494847